Zimmer Biomet is expected to launch a robot soon that will compete with Stryker's Mako Total Knee offering.
Zimmer Biomet CEO Bryan Hanson says the company must start reducing the size of its portfolio in order to simplify the supply chain and improve service levels to customers.
The Yokneam, Israel based company has the distinction of being one of the first companies to receive a nod from FDA for its exoskeleton technology.
Zimmer will partner with Apple to study the mymobility app’s impact on patient outcomes and overall costs for joint replacement patients.
Exploring the current state of robotic-assisted surgery and what to expect from future surgical robots.
Medtronic's new Infinity OCT system aligns navigation with biologics and devices for a more efficient spinal fusion procedure.
More than two years after Medtronic first hitched its wagon to Mazor Robotics, the pair is making it official through an acquisition valued at $1.64 billion, or $1.34 billion net of Medtronic's existing stake in Mazor and cash acquired.
The New Brunswick, NJ based company is looking to acquire Emerging Implant Technologies for an undisclosed sum.
A few months back, a Needham & Co. analyst noted that K2M was one of the 25 most attractive medtech companies on the M&A radar.
The new implant was specifically designed to simplify key stages of spinal fusion surgery to help restore spinal disc height between two vertebrae.
Stryker's 3D-printed Tritanium cages outperformed PEEK cages in terms of bone in-growth and fixation in a pre-clinical study using sheep.
NuVasive said the next evolution of its Reline system allows for greater procedural flexibility while enhancing visibility and access.